The Enterprise Value as of December 2024 (TTM) for Third Harmonic Bio, Inc. (THRD) is 172.31M

According to Third Harmonic Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 172.31M. This represents a change of -14.25% compared to the average of 200.96M of the last 4 quarters.

Third Harmonic Bio, Inc. (THRD) Historical Enterprise Value (quarterly & annually)

How has THRD Enterprise Value performed in the past?

The mean historical Enterprise Value of Third Harmonic Bio, Inc. over the last ten years is 308.40M. The current 172.31M Enterprise Value has changed 5.49% with respect to the historical average. Over the past ten years (40 quarters), THRD's Enterprise Value was at its highest in in the March 2022 quarter at 575.19M. The Enterprise Value was at its lowest in in the March 2023 quarter at -183852742.28.

Third Harmonic Bio, Inc. (THRD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Third Harmonic Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Third Harmonic Bio, Inc. (THRD) Average Enterprise Value

How has THRD Enterprise Value performed in the past?

The current Enterprise Value of Third Harmonic Bio, Inc. (THRD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Third Harmonic Bio, Inc. (THRD) Enterprise Value vs. Peers

How is THRD’s Enterprise Value compared to its peers?

Third Harmonic Bio, Inc.’s Enterprise Value is greater than Sensei Biotherapeutics, Inc. (-3241749.00), greater than NextCure, Inc. (2.00M), less than Nuvation Bio Inc. (930.27M), greater than Graphite Bio, Inc. (-15007658.00), greater than Merrimack Pharmaceuticals, Inc. (-10189682.00), less than Cullinan Oncology, Inc. (614.81M), less than Edgewise Therapeutics, Inc. (2.76B), greater than Rallybio Corporation (10.47M), less than Monte Rosa Therapeutics, Inc. (351.25M), greater than PMV Pharmaceuticals, Inc. (40.53M), greater than Enochian Biosciences, Inc. (167.08M), less than Revolution Medicines, Inc. (7.98B), greater than Passage Bio, Inc. (33.76M), greater than Werewolf Therapeutics, Inc. (-17421672.00), greater than Acrivon Therapeutics, Inc. Common Stock (154.58M), less than Eliem Therapeutics, Inc. (0),

Build a custom stock screener for Third Harmonic Bio, Inc. (THRD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Third Harmonic Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Third Harmonic Bio, Inc. (THRD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Third Harmonic Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.